Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Clinical Oncology|August 3, 2005
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancersGhassan K Abou-Alfa, Eric K Rowinsky, Yehuda Z Patt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumorsJeremy Kortmansky, Manish A Shah, Andreas Kaubisch, et al.
Future Oncology (London, England)|May 26, 2022
PD-L1 expression and overall survival in Asian and western patients with gastric cancerSun Young Rha, Geoffrey Y Ku, Hyo Song Kim, et al.
Journal of Hepatology|September 19, 2013
A phase II study of cixutumumab (IMC-A12, NSC742460) in advanced hepatocellular carcinomaGhassan K Abou-Alfa, Marinela Capanu, Eileen M O'Reilly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 30, 2022
Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for PracticeWungki Park, Catherine A O'Connor, Chaitanya Bandlamudi, et al.
Plos One|September 21, 2020
Induction and characterization of pancreatic cancer in a transgenic pig modelF Edward Boas, Fuad Nurili, Achiude Bendet, et al.
Cancer Medicine|October 25, 2021
Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancerTorben Steiniche, Sun Young Rha, Hyun Cheol Chung, et al.
Pageof 9